Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia
- 8 September 2009
- journal article
- Published by Springer Science and Business Media LLC in Molecular Medicine
- Vol. 15 (11-12), 438-445
- https://doi.org/10.2119/molmed.2009.00091
Abstract
Coagulation abnormalities are common in severe pneumonia and sepsis, yet little is known about the presence of coagulopathy or its significance in patients with lesser illness severity. We examined coagulation abnormalities in 939 subjects hospitalized with community-acquired pneumonia (CAP) in 28 US hospitals, hypothesizing that abnormalities would increase with illness severity and poor outcomes. We measured plasma coagulation markers (D-dimer, plasminogen activator inhibitor [PAI], antithrombin, factor IX, and thrombin-antithrombin complex [TAT]) at the time of patient presentation to the emergency department and daily during the first wk of hospitalization. Day-1 clinical laboratory test results for international normalized ratio, activated partial thromboplastin time, and platelet count were recorded from the medical record. In our cohort, 32.5% of patients developed severe sepsis and 11.1% died by d 90. Day-1 coagulation abnormalities were common, especially for D-dimer (80.6%) and TAT (36.0%), and increased with illness severity and poor outcomes. However, abnormalities also occurred in those patients who never developed organ dysfunction and differences between groups were modest. The proportion of patients with abnormalities changed over time, yet the magnitude of change was small and not always in the direction of normality. Many patients remaining in the hospital continued to manifest coagulation abnormalities on d 7, especially for D-dimer (86.5%) and TAT (36.9%). In conclusion, coagulation abnormalities were common and persistent in CAP patients, even among the least ill. These findings underscore the complexity of the coagulation response to infection and may offer insights into coagulation-based therapeutics in clinical sepsis trials.Keywords
This publication has 40 references indexed in Scilit:
- Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired PneumoniaAnnals of Emergency Medicine, 2008
- Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Understanding the Inflammatory Cytokine Response in Pneumonia and SepsisArchives of Internal Medicine, 2007
- Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired PneumoniaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumoniaBlood Coagulation & Fibrinolysis, 2003
- Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumoniaBlood, 2003
- The cytokine‐mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemiaEuropean Journal of Clinical Investigation, 1997
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986